Bone Biologics Corporation filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Weinberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | +6.00% | +8.90% | -64.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.82% | 1.4M | |
+13.31% | 129B | |
-9.43% | 10.92B | |
-2.59% | 8.5B | |
+37.50% | 5.5B | |
-22.36% | 4.69B | |
+7.87% | 3.42B | |
-11.25% | 2.73B | |
-14.85% | 2B | |
-13.29% | 1.93B |
- Stock Market
- Equities
- BBLG Stock
- News Bone Biologics Corporation
- Bone Biologics Corporation Auditor Raises 'Going Concern' Doubt